benzimidazole has been researched along with Macular Edema in 1 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Macular Edema: Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, T | 1 |
Morita, M | 1 |
Tojo, T | 1 |
Nagashima, A | 1 |
Moritomo, A | 1 |
Miyake, H | 1 |
1 other study available for benzimidazole and Macular Edema
Article | Year |
---|---|
Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatment.
Topics: Amine Oxidase (Copper-Containing); Amines; Animals; Cell Adhesion Molecules; Diabetes Mellitus, Expe | 2013 |